🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to investigate how Glucagon-Like Peptide 1 (GL...
Status
Completed
Location
Klinisk Institut, Afd. MEA, Aarhus Sygehus, NBG
Start Date
2011-05
Trial ID
NCT01333163
Treatments Being Tested
This is a medical research study designed to see if an infusion of a natura...
Status
Completed
Location
University of Pennsylvania
Start Date
2008-12
Trial ID
NCT00882492
Treatments Being Tested
This study investigates whether the gut hormone glucose-dependent insulinot...
Status
Enrolling By Invitation
Location
Center for Clinical Metabolic Research, Herlev-Gentofte Hospital
Start Date
2026-05-19
Trial ID
NCT07687589
Individuals with obesity have an increased risk for heart disease and diabe...
Status
Unknown
Location
Veteran's Affairs Clinical Research Unit
Start Date
2013-02
Trial ID
NCT01760772
The goal of this present proposal is to examine the efficacy of GLP-1 admin...
Status
Terminated
Location
Johns Hopkins Bayview Medical Center
Start Date
2008-12
Trial ID
NCT00798590
Treatments Being Tested
Ischaemic heart disease is the most common cause of death in the UK. Glucag...
Status
Completed
Location
Papworth Hospital
Start Date
2014-07
Trial ID
NCT02128022
Treatments Being Tested
The study team will invite participants with prediabetes or mild diabetes (...
Status
Not Yet Recruiting
Location
Stanford University
Start Date
2024-11
Trial ID
NCT06682351
GLP-1 is an incretin hormone that simulates insulin secretion and inhibits ...
Status
Completed
Location
Department of pharmacology, Aarhus university and Medical department M, Aarhus University hospital
Start Date
2005-12
Trial ID
NCT00285896
Treatments Being Tested
Comprehensive assessment of human vasodilatory effect of GLP-1 in forearm a...
Status
Completed
Location
Multiple Locations
Start Date
2015-12-01
Trial ID
NCT03502083
Treatments Being Tested
The purpose of this study is to determine the dose of the GLP-1 receptor an...
Status
Completed
Location
Ludwig Maximilians University, Clinical Research Unit
Start Date
2006-11
Trial ID
NCT00393445